Product
SPIKEVAX
Aliases
SARS-CoV-2-mRNA vaccine, SPIKEVAX Bivalent, SPIKEVAX Bivalent BA.1, SPIKEVAX BIVALENT BA.4/5, SPIKEVAX X (1 other aliases)
2 clinical trials
1 indication
Indication
COVID-19Clinical trial
A Multi-Centre, Prospective, Observational Post-Marketing Surveillance to Investigate the Long-Term Safety of SPIKEVAX BIVALENT and SPIKEVAX X Injection Under Routine Clinical Care in KoreaStatus: Recruiting, Estimated PCD: 2026-12-07
Clinical trial
Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran Vaccines in the United StatesStatus: Active (not recruiting), Estimated PCD: 2024-02-29